Stock of Hims & Hers Health, Inc. (HIMS) is climbing around 7 percent on Thursday morning trading over the announcement of an expansion of its weight loss specialty by enabling providers to prescribe a Compounded Semaglutide Pills starting at $49 per month.
The company's shares are currently trading at $26.19 on the New York Stock Exchange, up 7.09 percent. The stock opened at $26.09 and has climbed as high as $27.77 so far in today's session. Over the past year, it has traded in a range of $23.97 to $72.98.
The new Compounded Semaglutide Pill empowers providers to tailor treatments specifically for patients averse to needles or who are looking to help balance side effects.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.